Laurence Turka
2020
In 2020, Laurence Turka earned a total compensation of $2.4M as Chief Scientific Officer at Rubius Therapeutics.
Compensation breakdown
| Bonus | $312,693 |
|---|---|
| Option Awards | $1,706,495 |
| Salary | $380,513 |
| Other | $11,731 |
| Total | $2,411,432 |
Turka received $1.7M in option awards, accounting for 71% of the total pay in 2020.
Turka also received $312.7K in bonus, $380.5K in salary and $11.7K in other compensation.
Rankings
In 2020, Laurence Turka's compensation ranked 4,724th out of 13,090 executives tracked by ExecPay. In other words, Turka earned more than 63.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,724 out of 13,090 | 64th |
Division Manufacturing | 1,917 out of 5,621 | 66th |
Major group Chemicals And Allied Products | 750 out of 2,254 | 67th |
Industry group Drugs | 644 out of 1,954 | 67th |
Industry Biological Products, Except Diagnostic Substances | 150 out of 411 | 64th |
Source: SEC filing on March 30, 2021.
Turka's colleagues
We found three more compensation records of executives who worked with Laurence Turka at Rubius Therapeutics in 2020.